Entero Healthcare Solutions Limited — Important, 12-02-2025: Financial Result Updates

Consolidated financial results show Entero Healthcare Solutions Limited reported total revenue of ₹73,664.04 million for the quarter ended December 31, 2024, reflecting a 6.6% increase year-over-year, driven by improved demand in pharmaceutical products and recent acquisitions enhancing market presence.

Net profit for the quarter stands at ₹394.39 million, up from ₹83.23 million in the previous year, leading to an EPS of ₹5.85. The significant profit growth highlights effective cost management and operational efficiency amidst rising demand.

Total expenses increased to ₹15,270.55 million, with a notable 14.4% rise in purchase of stock-in-trade. Employee benefit expenses also reflected an increase, contributing to overall operational costs, which have risen as the company expands its workforce and operational footprint.

The balance sheet shows a healthy equity base, with total equity reported at ₹15,945.62 million, while cash flow appears stable, supporting ongoing operations and strategic investments.

The outlook remains positive, driven by continued expansion in the pharmaceutical sector and strategic acquisitions. Given the current financial performance and growth trajectory, a buy insight is indicated for potential investors looking at long-term gains.